China BioPharma Corp (fka CHBO)

[emulwa]

Ibox needs to be updated.
PRINCETON, N.J., June 21 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) announced that it has reached agreements with Soonfast Pharmaceutical Science & Technology Co., Ltd. ('Soonfast') to introduce a new antiviral medicine into the overseas market including the United States and European countries. This all-natural medicine has been approved in China for external use to treat human papillomavirus ('HPV') and herpes simplex virus ('HSV'). Tests have shown an inhibitory effect on the growth of HPV and HSV, and the medicine can reduce the infection from HPV and HSV by 90% only in 2-3 days. Experiments have also proved that the herbal can kill all of the HPV types 6/11/16/18 and 33.